How many acquisitions has Regeneron Pharmaceuticals made so far?

Regeneron Pharmaceuticals has completed 4 acquisitions so far, with an average acquisition amount of $575M.

In which year did Regeneron Pharmaceuticals make the most acquisitions?

Regeneron Pharmaceuticals was most active in 2022, with 2 acquisitions completed in that year.

List of 4 Acquisitions by Regeneron Pharmaceuticals (Apr 2026)

Q: Which is Regeneron Pharmaceuticals' latest acquisition?

Regeneron Pharmaceuticals's most recent acquisition is Oxular, a Developer of drug delivery platform and therapeutics for ophthalmology, acquired in January 2025.

Regeneron Pharmaceuticals has completed a total of 4 acquisitions. These include 2 in 2022, 1 in 2025, and 1 in 2023. The company's acquisition activity spans 2 countries, with 3 acquisitions in United States and 1 in United Kingdom, and has involved 5 sectors, notably Immunotherapy (2 acquisitions), Oncology (1 acquisition), and Ophthalmology (1 acquisition). Over the last five years (2020-2025), the average number of acquisitions per year has been 0.8, with 0 completed in the current calendar year. The most recent acquisition was Oxular, a developer of drug delivery platform and therapeutics for ophthalmology, founded in 2014, located in Oxford, and acquired in January 2025.

Here's the year on year acquisition history of Regeneron Pharmaceuticals:

Number of Total Acquisitions

Year	# Acquisitions
2025	1
2023	1
2022	2

View all Acquisitions by Regeneron Pharmaceuticals

Recent acquisitions by Regeneron Pharmaceuticals

Regeneron Pharmaceuticals's most recent acquisition - Oxular is a Developer of drug delivery platform and therapeutics for ophthalmology, founded in 2014 and located in Oxford. Regeneron Pharmaceuticals acquired it in January 2025 for a price of $*****.

Here is the list of all acquisitions by Regeneron Pharmaceuticals sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Jan 02, 2025	Oxular	jocz	btjm	29	365
Aug 10, 2023	Decibel Therapeutics	zfgq	tmku	85	233
Jun 02, 2022	LIBTAYO	nqpe	sp{j	38	129

View the full list of acquisitions

Media has covered Regeneron Pharmaceuticals for a total of 152 events in the last 1 year, 7 of them have been about acquisition activity.

•

OPKO Health Reports Fourth Quarter 2025 Business HighlightsGlobeNewswire•Feb 27, 2026•Opko Health, Regeneron Pharmaceuticals

•

Regeneron Pharma & Tessera Therapeutics Announce Global CollaborationBenzinga•Jan 30, 2026•Tessera Therapeutics, Regeneron Pharmaceuticals

•

Tessera inks $150M partnership deal with RegeneronEndpoints•Dec 01, 2025•Tessera Therapeutics, Regeneron Pharmaceuticals

•

Regeneron partners with Gary Nabel's ModeX on multispecificsEndpoints•Oct 29, 2025•ModeX Therapeutics, Regeneron Pharmaceuticals

•

Senhwa Biosciences Enters Immunotherapy Arena with CX-5461 & PD-1 Inhibitors CollaborationPR Newswire•Sep 16, 2025•Senhwa Biosciences, Regeneron Pharmaceuticals, Sanofi, Novavax

•

Strand Therapeutics raises $153M for ‘programmable’ mRNA drugs; Regeneron, Eli Lilly, and Amgen back the firmBioPharmaDive•Aug 08, 2025•Strand Therapeutics, Lilly, Regeneron Pharmaceuticals, Kinnevik and 12 others

•

23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing companyFOX Business•Jun 17, 2025•23andMe, TTAM Research Institute, Regeneron Pharmaceuticals

View More Regeneron Pharmaceuticals Recent News

View all Acquisitions by Regeneron Pharmaceuticals

Acquisitions by Regeneron Pharmaceuticals

List of Regeneron Pharmaceuticals's Acquisitions

Recent acquisitions by Regeneron Pharmaceuticals

News related to Regeneron Pharmaceuticals's acquisitions

FAQs about Acquisitions by Regeneron Pharmaceuticals